Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT00982150 · TERMINATED
Trial details
- NCT number
- NCT00982150
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-06-01
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.